Chie Emoto

1.9k total citations
70 papers, 1.5k citations indexed

About

Chie Emoto is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Chie Emoto has authored 70 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pharmacology, 24 papers in Oncology and 23 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Chie Emoto's work include Pharmacogenetics and Drug Metabolism (35 papers), Drug Transport and Resistance Mechanisms (24 papers) and Renal Transplantation Outcomes and Treatments (11 papers). Chie Emoto is often cited by papers focused on Pharmacogenetics and Drug Metabolism (35 papers), Drug Transport and Resistance Mechanisms (24 papers) and Renal Transplantation Outcomes and Treatments (11 papers). Chie Emoto collaborates with scholars based in United States, Japan and United Kingdom. Chie Emoto's co-authors include Tsuyoshi Fukuda, Alexander A. Vinks, Hiroshi Yamazaki, Kenji Iwasaki, Norie Murayama, Kazuhide Iwasaki, Tomoyuki Mizuno, David Hahn, Amin Rostami‐Hodjegan and Toshiro Niwa and has published in prestigious journals such as Blood, British Journal of Pharmacology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Chie Emoto

65 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chie Emoto United States	24	667	453	384	270	202	70	1.5k
Jeannine M. Fisher United States	15	901 1.4×	759 1.7×	380 1.0×	175 0.6×	232 1.1×	18	1.6k
Rheem A. Totah United States	24	1.1k 1.6×	409 0.9×	227 0.6×	197 0.7×	360 1.8×	56	1.9k
S-M Huang United States	15	685 1.0×	611 1.3×	534 1.4×	221 0.8×	322 1.6×	16	1.8k
Shirley M. Tsunoda United States	17	461 0.7×	316 0.7×	261 0.7×	126 0.5×	226 1.1×	47	1.1k
Mitchell A. Hamman United States	18	1.3k 1.9×	734 1.6×	388 1.0×	341 1.3×	256 1.3×	22	2.0k
Akihiro Hisaka Japan	21	516 0.8×	495 1.1×	242 0.6×	251 0.9×	295 1.5×	91	1.5k
Jin‐ding Huang Taiwan	21	1.0k 1.6×	779 1.7×	351 0.9×	210 0.8×	468 2.3×	61	1.9k
Johanna Sistonen Finland	18	728 1.1×	345 0.8×	300 0.8×	152 0.6×	242 1.2×	34	1.3k
Jouko Laitila Finland	25	1.0k 1.5×	845 1.9×	422 1.1×	293 1.1×	371 1.8×	33	2.1k
Tomonori Tateishi Japan	27	794 1.2×	605 1.3×	378 1.0×	337 1.2×	170 0.8×	56	1.6k

Countries citing papers authored by Chie Emoto

Since Specialization

Citations

This map shows the geographic impact of Chie Emoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chie Emoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chie Emoto more than expected).

Fields of papers citing papers by Chie Emoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chie Emoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chie Emoto. The network helps show where Chie Emoto may publish in the future.

Co-authorship network of co-authors of Chie Emoto

This figure shows the co-authorship network connecting the top 25 collaborators of Chie Emoto. A scholar is included among the top collaborators of Chie Emoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chie Emoto. Chie Emoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tachibana, Tatsuhiko, et al.. (2025). Quantitative prediction of CYP2C9-mediated drug disposition using humanized mice. Drug Metabolism and Disposition. 53(12). 100185–100185.

Mochizuki, Tatsuki, Mikiko Nakamura, Chie Emoto, et al.. (2023). Quantitative prediction of CYP3A‐mediated drug–drug interactions by correctly estimating fraction metabolized using human liver chimeric mice. British Journal of Pharmacology. 181(7). 1091–1106. 8 indexed citations

Emoto, Chie & Trevor N. Johnson. (2022). Cytochrome P450 enzymes in the pediatric population: Connecting knowledge on P450 expression with pediatric pharmacokinetics. Advances in pharmacology. 95. 365–391. 4 indexed citations

Emoto, Chie, Makiko Shimizu, Toshihiro Tanaka, & Hiroshi Yamazaki. (2021). Feasibility of physiologically based pharmacokinetic simulations for assessing pediatric patients after accidental drug ingestion: A case study of a 1.4-year-old girl who ingested alprazolam. Drug Metabolism and Pharmacokinetics. 39. 100394–100394. 7 indexed citations

Emoto, Chie, et al.. (2020). Applications of PBPK Modeling and Simulations in The Clinical Pharmacology Field: Lessons from Several Case Studies. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 51(6). 331–344.

Emoto, Chie & Tsuyoshi Fukuda. (2020). Applications of Pediatric PBPK Modeling: Current Status for Drug Development Processes and Use in Clinical Settings. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 51(5). 267–276. 1 indexed citations

Hahn, David, Tsuyoshi Fukuda, Joshua C. Euteneuer, et al.. (2020). Influence of MRP3 Genetics and Hepatic Expression Ontogeny for Morphine Disposition in Neonatal and Pediatric Patients. The Journal of Clinical Pharmacology. 60(8). 992–998. 9 indexed citations

Miyake, Masateru, Satoshi Kondo, Toshihisa Koga, et al.. (2017). Evaluation of intestinal metabolism and absorption using the Ussing chamber system equipped with intestinal tissue from rats and dogs. European Journal of Pharmaceutics and Biopharmaceutics. 122. 49–53. 13 indexed citations

Miyake, Masateru, et al.. (2017). Arachidonic acid with taurine enhances pulmonary absorption of macromolecules without any serious histopathological damages. European Journal of Pharmaceutics and Biopharmaceutics. 114. 22–28. 5 indexed citations

10.

Mihara, Sachiko, et al.. (2016). Discovery of small-molecule nonpeptide antagonists of nociceptin/orphanin FQ receptor: The studies of design, synthesis, and structure–activity relationships for (4-arylpiperidine substituted-methyl)-[bicyclic (hetero)cycloalkanobenzene] derivatives. European Journal of Medicinal Chemistry. 114. 345–364. 3 indexed citations

11.

Miyake, Masateru, Toshihisa Koga, Satoshi Kondo, et al.. (2016). Prediction of drug intestinal absorption in human using the Ussing chamber system: A comparison of intestinal tissues from animals and humans. European Journal of Pharmaceutical Sciences. 96. 373–380. 37 indexed citations

12.

Khandelwal, Pooja, Chie Emoto, Tsuyoshi Fukuda, et al.. (2016). A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(12). 2220–2225. 18 indexed citations

13.

Emoto, Chie, Tsuyoshi Fukuda, Tomoyuki Mizuno, et al.. (2014). Age-Dependent Changes in Sirolimus Metabolite Formation in Patients With Neurofibromatosis Type 1. Therapeutic Drug Monitoring. 37(3). 395–399. 11 indexed citations

14.

Nakata, Eriko, et al.. (2012). Discovery of 1-(β-amino substituted-β-alanyl)-N,N-dimethylindoline-2-carboxamides as novel nonpeptide antagonists of nociceptin/orphanin FQ receptor: Efficient design, synthesis, and structure–activity relationship studies. European Journal of Medicinal Chemistry. 55. 228–242. 5 indexed citations

15.

Emoto, Chie, et al.. (2009). Effects of Histidine-Tag on Recombinant Human Cytochrome P450 3A5 Catalytic Activity in Reconstitution Systems. Drug Metabolism Letters. 3(4). 207–211. 10 indexed citations

16.

Maekawa, Keiko, Takuya Yoshimura, Yoshiro Saito, et al.. (2009). Functional characterization of CYP3A4.16: Catalytic activities toward midazolam and carbamazepine. Xenobiotica. 39(2). 140–147. 26 indexed citations

17.

Emoto, Chie, Norie Murayama, & Hiroshi Yamazaki. (2008). Effects of Enzyme Sources on Midazolam 1-Hydroxylation Activity Catalyzed by Recombinant Cytochrome P450 3A4 in Combination with NADPH-Cytochrome P450 Reductase. Drug Metabolism Letters. 2(3). 190–192. 8 indexed citations

18.

Emoto, Chie & Kenji Iwasaki. (2006). Enzymatic characteristics of CYP3A5 and CYP3A4: A comparison ofin vitrokinetic and drug–drug interaction patterns. Xenobiotica. 36(2-3). 219–233. 39 indexed citations

19.

Emoto, Chie, et al.. (2006). Approach to the prediction of the contribution of major cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage. Xenobiotica. 36(8). 671–683. 31 indexed citations

20.

Kawahara, Masami, Tomoyuki Ishida, Chie Emoto, et al.. (2001). Determination of a Pain Substance Produced by the Photodegradation of Dacarbazine.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 32(1). 15–22. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact